Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide in healthy participants within a novel intervention paradigm: Qualitative results from a proof-of-concept study

被引:3
作者
Hendricks, Peter S. [1 ]
Copes, Heith [1 ]
Family, Neiloufar [2 ]
Williams, Luke T. J. [2 ]
Luke, David [3 ]
Raz, Shlomi [4 ]
机构
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Eleusis Hlth Solut Ltd, 50 Grosvenor Hill, London W1K 3QT, England
[3] Univ Greenwich, Old Royal Naval Coll, Ctr Mental Hlth, Sch Human Sci, Greenwich, England
[4] Eleusis Hlth Solut US, New York, NY USA
关键词
Implementation science; LSD; psychedelics; psychotherapy; qualitative research; thematic analysis; LSD-ASSISTED PSYCHOTHERAPY; DOSE-RESPONSE; PSILOCYBIN; GUIDELINES; STATES;
D O I
10.1177/02698811211055855
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Classic psychedelics show promise in the treatment of mental health conditions; however, more scalable intervention protocols are needed to maximize access to these novel therapeutics. In this proof-of-concept study, perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide (LSD) were evaluated among healthy participants (N = 31) administered 50 to 100 mu g LSD in a treatment paradigm conceptualized as more scalable than traditional approaches to administering classic psychedelics. Methods: Semi-structured interviews assessed participants' expectations, experience, and thoughts on the safety and efficacy of the study design. These interviews were transcribed for thematic analysis relating to perceptions of safety, subjective effects, and beliefs about the clinical utility of LSD. Results: Most participants felt safe throughout the study, with a minority reporting concerns related to having a challenging experience that diminished over time. Participants attributed their feelings of safety to the study structure and support of their attendants, which allowed them to "let go" and immerse themselves in the experience without pre-occupation. Furthermore, participants reported transcendent, mystical-type experiences characteristic of classic psychedelics, with almost half highlighting the prominent role played by music during the acute period of drug action. Finally, participants endorsed support for the clinical utility of LSD in controlled environments, expressing the belief that LSD is safe and has the potential to help others. Conclusion: Findings provide preliminary support for the feasibility of this scalable interventional paradigm and set the stage for future critical research with clinical populations.
引用
收藏
页码:337 / 347
页数:11
相关论文
共 45 条
[1]   Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects [J].
Aday, Jacob S. ;
Davis, Alan K. ;
Mitzkovitz, Cayla M. ;
Bloesch, Emily K. ;
Davoli, Christopher C. .
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2021, 4 (02) :424-435
[2]   Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study [J].
Anderson, Brian T. ;
Danforth, Alicia ;
Daroff, Robert ;
Stauffer, Christopher ;
Ekman, Eve ;
Agin-Liebes, Gabrielle ;
Trope, Alexander ;
Boden, Matthew Tyler ;
Dilley, James ;
Mitchell, Jennifer ;
Woolley, Joshua .
ECLINICALMEDICINE, 2020, 27
[3]   Psychedelics and music: neuroscience and therapeutic implications [J].
Barrett, Frederick S. ;
Preller, Katrin H. ;
Kaelen, Mendel .
INTERNATIONAL REVIEW OF PSYCHIATRY, 2018, 30 (04) :350-362
[4]   Neuroticism is associated with challenging experiences with psilocybin mushrooms [J].
Barrett, Frederick S. ;
Johnson, Matthew W. ;
Griffiths, Roland R. .
PERSONALITY AND INDIVIDUAL DIFFERENCES, 2017, 117 :155-160
[5]   Regulation of human research with LSD in the United States (1949-1987) [J].
Bonson, Katherine R. .
PSYCHOPHARMACOLOGY, 2018, 235 (02) :591-604
[6]   Using Cost-Effectiveness Evidence to Inform Decisions as to which Health Services to Provide [J].
Cairns, John .
HEALTH SYSTEMS & REFORM, 2016, 2 (01) :32-38
[7]   LSD enhances suggestibility in healthy volunteers [J].
Carhart-Harris, R. L. ;
Kaelen, M. ;
Whalley, M. G. ;
Bolstridge, M. ;
Feilding, A. ;
Nutt, D. J. .
PSYCHOPHARMACOLOGY, 2015, 232 (04) :785-794
[8]   Trial of Psilocybin versus Escitalopram for Depression [J].
Carhart-Harris, Robin ;
Giribaldi, Bruna ;
Watts, Rosalind ;
Baker-Jones, Michelle ;
Murphy-Beiner, Ashleigh ;
Murphy, Roberta ;
Martell, Jonny ;
Blemings, Allan ;
Erritzoe, David ;
Nutt, David J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (15) :1402-1411
[9]   Neural correlates of the LSD experience revealed by multimodal neuroimaging [J].
Carhart-Harris, Robin L. ;
Muthukumaraswamy, Suresh ;
Roseman, Leor ;
Kaelen, Mendel ;
Droog, Wouter ;
Murphy, Kevin ;
Tagliazucchi, Enzo ;
Schenberg, Eduardo E. ;
Nest, Timothy ;
Orban, Csaba ;
Leech, Robert ;
Williams, Luke T. ;
Williams, Tim M. ;
Bolstridge, Mark ;
Sessa, Ben ;
McGonigle, John ;
Sereno, Martin I. ;
Nichols, David ;
Hellyer, Peter J. ;
Hobden, Peter ;
Evans, John ;
Singh, Krish D. ;
Wise, Richard G. ;
Curran, H. Valerie ;
Feilding, Amanda ;
Nutt, David J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (17) :4853-4858
[10]   Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial [J].
Davis, Alan K. ;
Barrett, Frederick S. ;
May, Darrick G. ;
Cosimano, Mary P. ;
Sepeda, Nathan D. ;
Johnson, Matthew W. ;
Finan, Patrick H. ;
Griffiths, Roland R. .
JAMA PSYCHIATRY, 2021, 78 (05) :481-489